Economy
Video: GSK clinches deal to buy Human Genome Add to ...
GlaxoSmithKline is to acquire its long-time partner Human Genome Sciences for about $3-billion, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer

